Collections: Health Policy and Services Research / Subjects: United States - Digital Collections - National Library of Medicine Search Results

Start Over Collections Health Policy and Services Research ✖ Subjects United States ✖ Publication Year 2018 ✖

431. Zika supplemental funding: status of HHS agencies' obligations, disbursements, and the activities funded : report to Congressional committees

Publication:: Washington, DC : United States Government Accountability Office, May 2018
Subject(s):: Zika Virus Infection -- economics
Zika Virus Infection -- prevention & control
Financing, Government
United States
United States. Department of Health and Human Services.
United States. Health Resources and Services Administration.
Centers for Medicare & Medicaid Services (U.S.)

432. Medicare: small and rural practices' experiences in previous programs and expected performance in the Merit-based Incentive Payment System : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, May 2018
Subject(s):: Medicare -- economics
Reimbursement, Incentive
Rural Health Services
United States

433. Drug discount program: status of agency efforts to improve 340B program oversight : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate

Publication:: Washington, DC : United States Government Accountability Office, May 15, 2018
Subject(s):: Drug Costs
Economics, Pharmaceutical
Government Regulation
Medicaid -- economics
United States
United States. Health Resources and Services Administration.

434. Drug discount program: federal oversight of compliance at 340B contract pharmacies needs improvement : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, June 2018
Subject(s):: Drug Costs
Economics, Pharmaceutical
Pharmacies -- economics
Contract Services
United States
United States. Health Resources and Services Administration.

435. Medicaid: actions needed to mitigate billions in improper payments and program integrity risks : testimony before the Committee on Homeland Security and Governmental Affairs, U.S. Senate

Publication:: Washington, DC : United States Government Accountability Office, June 27, 2018
Subject(s):: Fraud -- prevention & control
Medicaid
United States
Centers for Medicare & Medicaid Services (U.S.)

436. Medicare fee-for-service: information on the first year of nationwide reduced payment rates for durable medical equipment : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, July 2018
Subject(s):: Durable Medical Equipment -- economics
Medicare -- economics
Competitive Bidding
Fee-for-Service Plans -- economics
United States
Centers for Medicare & Medicaid Services (U.S.)

437. Health insurance exchanges: HHS should enhance its management of open enrollment performance : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, July 2018
Subject(s):: Health Insurance Exchanges
Community-Institutional Relations
United States
United States. Department of Health and Human Services.
United States.

438. Medicaid managed care: improvements needed to better oversee payment risks : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, July 2018
Subject(s):: Managed Care Programs -- economics
Medicaid -- economics
Insurance, Health, Reimbursement
Fraud -- economics
United States
Centers for Medicare & Medicaid Services (U.S.)

439. Social Security disability: better timeliness metrics needed to assess transfers of appeals work : report to Congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, July 2018
Subject(s):: Disability Evaluation
Eligibility Determination
Social Security
United States
United States. Social Security Administration.

440. Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, July 11, 2018
Subject(s):: Drug Costs
Economics, Pharmaceutical
Pharmacies -- economics
Contract Services
Government Regulation
United States
United States. Health Resources and Services Administration.

« Previous
Next »
1
2
…
40
41
42
43
44
45
46
47
48
49